|
|
Budget impact of GCSF biosimilars
| Third-party funded project |
| Project title |
Budget impact of GCSF biosimilars |
| Principal Investigator(s) |
Schwenkglenks, Matthias
|
| Organisation / Research unit |
Departement Public Health / Pharmazeutische Medizin (Szucs) |
| Project start |
15.01.2020 |
| Probable end |
30.06.2020 |
| Status |
Completed |
| Abstract |
Budget impact of GCSF biosimilars in Switzerland, for different pricing strategies/assumptions. |
| Financed by |
Private Sector / Industry
|
| |
|
|
MCSS v5.8 PRO. 0.424 sec, queries - 0.000 sec
©Universität Basel | Impressum
|  |
|
27/04/2024
Research Database / FORSCHUNGSDATENBANK
|
